We thank Dr. So, et al1 for the interest in our letter2 and for sharing the results about the coronavirus disease 2019 (COVID-19) in patients with systemic lupus erythematosus (SLE) in Hong Kong1 We agree that the quantification of the risk of infection with severe acute respiratory coronaviruses-2 (SARS-CoV-2) in patients with SLE is a major concern.
Dr. Favalli, et al. reply / E.G. Favalli, E. Agape, R. Caporali. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - (2020). [Epub ahead of print]
Dr. Favalli, et al. reply
E.G. Favalli;R. Caporali
2020
Abstract
We thank Dr. So, et al1 for the interest in our letter2 and for sharing the results about the coronavirus disease 2019 (COVID-19) in patients with systemic lupus erythematosus (SLE) in Hong Kong1 We agree that the quantification of the risk of infection with severe acute respiratory coronaviruses-2 (SARS-CoV-2) in patients with SLE is a major concern.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
jrheum.200723.full.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
188.6 kB
Formato
Adobe PDF
|
188.6 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
